238403-53-7

Usage

Uses

Used in Pharmaceutical Industry:
4,6-DIFLUORO-4,6-DIDEOXY-D-GALACTOPYRANOSE is used as a pharmaceutical compound for its potential therapeutic applications. Its unique structure allows it to interact with biological targets, making it a promising candidate for the development of new drugs and therapies.
Used in Carbohydrate-based Material Development:
4,6-DIFLUORO-4,6-DIDEOXY-D-GALACTOPYRANOSE is used as a building block for the synthesis of new carbohydrate-based materials and compounds. Its deoxy characteristic and the presence of fluorine atoms provide unique properties that can be exploited in the design and synthesis of novel materials with specific functionalities.
Used in Research Applications:
4,6-DIFLUORO-4,6-DIDEOXY-D-GALACTOPYRANOSE is used as a research compound to study its properties and explore its potential applications. Its unique structure and properties make it an interesting subject for scientific investigations, which can lead to a better understanding of its behavior and potential uses in various fields.

InChI:InChI=1/C6H10F2O4/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-6,9-11H,1H2/t2-,3+,4+,5-,6-/m1/s1

Upstream product

• 84073-36-9 Methyl 4,6-Dideoxy-4,6-difluoro-α-D-talopyranoside 
• 97-30-3 methyl-alpha-D-glucopyranoside 
• 79291-95-5 Methyl 4,6-Dideoxy-4,6-difluoro-α-D-galactopyranoside 
• 176897-11-3 (2'R,3'R)-methyl-2,3-O-(2',3'-dimethoxybutane-2',3'-diyl)-a-D-galactopyranoside 
• 87586-04-7 Methyl 4,6-Dideoxy-4,6-difluoro-α-D-glucopyranoside 
• 617-04-9 (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol 

Relevant academic research and scientific papers

Synthesis and Structural Characteristics of all Mono- And Difluorinated 4,6-Dideoxy- d - Xylo-hexopyranoses

Protein-carbohydrate interactions are implicated in many biochemical/biological processes that are fundamental to life and to human health. Fluorinated carbohydrate analogues play an important role in the study of these interactions and find application a

Addressing the Structural Complexity of Fluorinated Glucose Analogues: Insight into Lipophilicities and Solvation Effects

In this work, we synthesized all mono-, di-, and trifluorinated glucopyranose analogues at positions C-2, C-3, C-4, and C-6. This systematic investigation allowed us to perform direct comparison of 19F resonances of fluorinated glucose analogues and also to determine their lipophilicities. Compounds with a fluorine atom at C-6 are usually the most hydrophilic, whereas those with vicinal polyfluorinated motifs are the most lipophilic. Finally, the solvation energies of fluorinated glucose analogues were assessed for the first time by using density functional theory. This method allowed the log P prediction of fluoroglucose analogues, which was comparable to the C log P values obtained from various web-based programs.

Overproduction of CMP-sialic acid synthetase for organic synthesis

The gene coding for Escherichia coli CMP-sialic acid synthetase (E.G. 2.7.7.43) was cloned and overexpressed in E. coli through a primer-directed polymerase chain reaction. Two plasmids were constructed to produce the native enzyme and a modified enzyme f

The synthesis and hydrolysis of a series of deoxy- and deoxyfluoro-α-D-"glucopyranosyl" phosphates

The syntheses of three deoxy-α-D-"glucopyranosyl" phosphates and a series of dideoxymonofluoro- and dideoxydifluoro-α-D-glucopyranosyl phosphates are described.Rate constants for their acid-catalyzed hydrolysis were determined.Deoxygenation in the sugar r